Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Shares
  3. Deys Medical Stores

Deys Medical Stores Unlisted Share Price Today

ISIN INE00H901015.

Dey’s Medical Stores (Manufacturing) is an Indian pharmaceutical manufacturing company engaged in the production and distribution of a wide range of therapeutic formulations, including antibiotics, gastrointestinal medicines, ophthalmic products, and other healthcare formulations. The company focuses on delivering affordable medicines and healthcare solutions to address the high disease burden in India. Dey’s Medical follows a manufacturing-driven business model, supported by GMP-compliant pr…

Deys Medical Stores

Login for availability
Deys Medical Stores

Deys Medical Stores Unlisted Share Price Today

Current Price
Login for availability
Loading chart data...
SectorHealthcare & Pharmaceuticals
ISININE00H901015
Depository
Market Cap₹0.09 Cr
P/E Ratio0.02
ROE (%)4.37
Revenue₹125.56 Cr
Book Value1039.84
Debt to EquityN/A
Face Value10
52W HighN/A
52W LowN/A
Market Cap₹0.09 Cr
P/E Ratio0.02
ROE (%)4.37
Revenue₹125.56 Cr
Book Value1039.84
Debt to EquityN/A
52W High/LowN/A
Face Value10
As of FY25

About the company & Industry

About Company

Dey’s Medical Stores (Manufacturing) is an Indian pharmaceutical manufacturing company engaged in the production and distribution of a wide range of therapeutic formulations, including antibiotics, gastrointestinal medicines, ophthalmic products, and other healthcare formulations. The company focuses on delivering affordable medicines and healthcare solutions to address the high disease burden in India.

Dey’s Medical follows a manufacturing-driven business model, supported by GMP-compliant production facilities and a diversified product portfolio across multiple therapeutic segments. Its operations are focused on expanding access to cost-effective medicines, with manufacturing units established in Kolkata and Allahabad and a broad presence across Indian pharmaceutical markets. 

Founded in 1941 and headquartered in Kolkata, West Bengal, Dey’s Medical has built a legacy of over 75 years in the pharmaceutical industry. The company operates as an integrated pharmaceutical manufacturer, producing drugs for human and veterinary use and supplying them through a nationwide distribution network.

About Company

Dey’s Medical Stores (Manufacturing) is an Indian pharmaceutical manufacturing company engaged in the production and distribution of a wide range of therapeutic formulations, including antibiotics, gastrointestinal medicines, ophthalmic products, and other healthcare formulations. The company focuses on delivering affordable medicines and healthcare solutions to address the high disease burden in India.

Dey’s Medical follows a manufacturing-driven business model, supported by GMP-compliant production facilities and a diversified product portfolio across multiple therapeutic segments. Its operations are focused on expanding access to cost-effective medicines, with manufacturing units established in Kolkata and Allahabad and a broad presence across Indian pharmaceutical markets. 

Founded in 1941 and headquartered in Kolkata, West Bengal, Dey’s Medical has built a legacy of over 75 years in the pharmaceutical industry. The company operates as an integrated pharmaceutical manufacturer, producing drugs for human and veterinary use and supplying them through a nationwide distribution network.

Financials

Declining Revenue Growth

Revenue from operations fell by 2.35% YoY in FY25, indicating weakening sales momentum.

Sharp Profitability Compression

EBITDA margin dropped from 10.09% to 5.46%, reflecting significant pressure on operating efficiency.

Stable but Low Profitability

PAT margin declined to 3.30% in FY25, indicating the company remains profitable but with thin margins relative.

Income Statement

Revenue(Figures in Cr.)

Declining Revenue Growth

Revenue from operations fell by 2.35% YoY in FY25, indicating weakening sales momentum.

Sharp Profitability Compression

EBITDA margin dropped from 10.09% to 5.46%, reflecting significant pressure on operating efficiency.

Stable but Low Profitability

PAT margin declined to 3.30% in FY25, indicating the company remains profitable but with thin margins relative.

Income Statement

Revenue(Figures in Cr.)

Competitive Position

Market Share

P/E Ratio

Financial Ratio Comparison (FY25)

Particulars
Deys Medical Stores
FDC Ltd.
Ajanta Pharma Ltd.
Revenue (₹ Cr)125.562108.124648.10
Revenue Growth (%)-2.358.5010.44
EBITDA Margin (%)5.4619.7129.13
Net Profit Margin (%)3.3012.6519.80
ROE (%)4.3712.1925.02
Debt to Equity0.000.000.00
Asset Turnover Ratio (x)0.990.810.96
ROCE (%)5.29--
ROA (%)3.27--
Fixed Asset Turnover Ratio (x)17.832.572.86
Cash Conversion Ratio (x)-0.310.760.85

Market Share

P/E Ratio

Financial Ratio Comparison (FY25)

Particulars
Deys Medical Stores
FDC Ltd.
Ajanta Pharma Ltd.
Revenue (₹ Cr)125.562108.124648.10
Revenue Growth (%)-2.358.5010.44
EBITDA Margin (%)5.4619.7129.13
Net Profit Margin (%)3.3012.6519.80
ROE (%)4.3712.1925.02
Debt to Equity0.000.000.00
Asset Turnover Ratio (x)0.990.810.96
ROCE (%)5.29--
ROA (%)3.27--
Fixed Asset Turnover Ratio (x)17.832.572.86
Cash Conversion Ratio (x)-0.310.760.85

Management

Shareholding PatternAs of FY26
Promoters
98.27%
Others
1.73%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Mr. Gautam Dey
Managing Director
Mr. Ranajit Dey
Joint Managing Director

Shareholding PatternAs of FY26
Promoters
98.27%
Others
1.73%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Mr. Gautam Dey
Managing Director
Mr. Ranajit Dey
Joint Managing Director
Coming Soon

Register to view prices and access exclusive investments.

Minimum ticket ₹10,000 - Start small. No large capital lock-in.
Reserve Access
or
Continue with Google
Reserve Access

FAQs on Deys Medical Stores Unlisted Shares

What is the unlisted share price today?

unlisted share price is updated regularly on Precize. Visit Precize to check price movements and market trends.

How do I buy unlisted shares?

Register on Precize.in, complete KYC, select , enter quantity, and pay via UPI or NEFT. Shares are transferred within 24 hours.

What is 's revenue and profitability?

Please read these important legal notices and disclosures

None of the information displayed on or downloadable from https://www.precize.in represents an offer to buy or sell or a solicitation of an offer to buy or sell any security, nor does it constitute an offer to provide investment advice or service. Registered representatives of precize do not (1) Advise any member on the merits or advisability of a particular investment or transaction, or (2) Assist in the determination of fair value of any security or investment, or (3) Provide legal, tax, or transactional advisory services.

Read more

© 2026 Precize All Rights Reserved.

DECLARATION OF RISKTERMS OF USEPRIVACY POLICY
reported revenue of ₹125.56 Cr in FYFY25. PAT was ₹4.14 Cr. See full financials on this page.

What is the minimum investment for unlisted shares?

Minimum investment for unlisted shares starts from ₹10000. Please log in to view the latest pricing and availability